Jinyu Bio-technology Co., Ltd. (SHA:600201)

China flag China · Delayed Price · Currency is CNY
14.04
+0.46 (3.39%)
Apr 29, 2026, 1:25 PM CST
107.39%
Market Cap 14.84B
Revenue (ttm) 1.33B
Net Income (ttm) 100.76M
Shares Out 1.09B
EPS (ttm) 0.10
PE Ratio 141.34
Forward PE 56.58
Dividend 0.04 (0.27%)
Ex-Dividend Date Jun 26, 2025
Volume 20,348,107
Average Volume 21,931,130
Open 13.66
Previous Close 13.58
Day's Range 13.60 - 14.15
52-Week Range 6.76 - 19.00
Beta 0.90
RSI 42.58
Earnings Date Apr 23, 2026

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies ther... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 1,740
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600201
Full Company Profile

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.

Financial Statements

News

There is no news available yet.